Some of S&P's data products such as Compustat for financial statement data are collected from public filings, such as SEC 10K, 10Q, 8K filings. Do you think the AI disruption would narrow the gap between it and any less (human-)resourceful competitor in the data vendor space?
TI, great question. The argument against that is the overall datasets, which have taken decades to create. And a bunch of it is well beyond SEC filings. I'm assuming the likes of SEC filings are low-hanging fruit.
Herb, company analysis doesn’t get any better than this, especially because you did make reference.to its exceptional dividend growth over the past five years. And, in that same sentence you did make reference to its stock buybacks. Unfortunately, any stock buyback at a P/B Ratio of greater than 1/1 represents a failure of management's fiduciary duty to the remaining shareholders. The auditor’s failure to note that fact, also represents their fiduciary failure to the remaking shareholders! If you would like incontrovertible proof from the company’s most recent audited financial statement contact me privately.
I am a former subscriber of Empire financial research and loved reading your newsletters and stock picks. I also made handsome returns on almost all of your recommendations. Very impressed with your analysis. I just found you are writing here, glad to be able to connect with you again and looking forward to reading more of your insights.
Herb Excellent article as always- If you get time or the inclination can you dive into CRSP and the recent approval both Blue and CRSP were approved but it seemed like big side effects with BLUE...
Well done as always. A bit richly valued for my taste right now. But your post is tempting me to buy a small amount now and then scale in on significant pullbacks.
Some of S&P's data products such as Compustat for financial statement data are collected from public filings, such as SEC 10K, 10Q, 8K filings. Do you think the AI disruption would narrow the gap between it and any less (human-)resourceful competitor in the data vendor space?
TI, great question. The argument against that is the overall datasets, which have taken decades to create. And a bunch of it is well beyond SEC filings. I'm assuming the likes of SEC filings are low-hanging fruit.
As usual, Herb provides thoughtful information! Way to go, young sir!
Thanks, John!
Herb, company analysis doesn’t get any better than this, especially because you did make reference.to its exceptional dividend growth over the past five years. And, in that same sentence you did make reference to its stock buybacks. Unfortunately, any stock buyback at a P/B Ratio of greater than 1/1 represents a failure of management's fiduciary duty to the remaining shareholders. The auditor’s failure to note that fact, also represents their fiduciary failure to the remaking shareholders! If you would like incontrovertible proof from the company’s most recent audited financial statement contact me privately.
Hi Herb,
I am a former subscriber of Empire financial research and loved reading your newsletters and stock picks. I also made handsome returns on almost all of your recommendations. Very impressed with your analysis. I just found you are writing here, glad to be able to connect with you again and looking forward to reading more of your insights.
You just made my day, Chun! Glad you found me!!!!
Didn’t know S&P owns Carfax. Guess that means a fox is their mascot?
Neither did I!
Thanks, Herb. Perceptive as always. Recommended to my Boomberg Substack readers.
Herb Excellent article as always- If you get time or the inclination can you dive into CRSP and the recent approval both Blue and CRSP were approved but it seemed like big side effects with BLUE...
Thank for the idea. Unfortunately, out of my sphere right now. (I take it you are not the James Ellis I know.)
well I Iive in Los Angeles and have read you on various platforms for a very long time. Thanks very much for allowing us into your "ideas bucket".
Well done as always. A bit richly valued for my taste right now. But your post is tempting me to buy a small amount now and then scale in on significant pullbacks.
Fantastic article as always!